A more tamper-proof formulation of extended-release Oxycodone DETERx (Collegium Pharmaceutical Inc) could help to minimize abuse of the opioid drug. Topline results of a new study show that crushing ...

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration. Soft capsule formulation technology ...

Softgel Capsules Market · GlobeNewswire Inc. Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "Softgel Capsules Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.

Cyclosporine has revolutionised the transplantation scene in the last 20 years by helping with immunosuppresion. Novartis have so far had the patent Cyclosporine has revolutionised the transplantation ...

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced FDA approval of a new capsule dose formulation and a new tablet strength of NUPLAZID (pimavanserin) to help in ...

Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing ...

Phase I study of imetelstat (GRN163L) in combination with paclitaxel (P) and bevacizumab (B) in patients (pts) with locally recurrent or metastatic breast cancer (MBC). Methods: In this randomized, ...

The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...

Introduction: Different oral sustained-release (SR) formulations of tramadol have been introduced in pain treatment in order to prolong the dosage interval to improve convenience for the patient. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...

Lone Star has entered into a definitive agreement to acquire the Capsules and Health Ingredients division of Lonza Group. Lonza will retain a 40 percent equity position in the business.